• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    Intercept Pharmaceuticals, Inc. (ICPT)

    -NasdaqGS
    283.20 0.00(0.00%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Prev Close:283.20
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:413.75
    Beta:-9.08
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:N/A - N/A
    52wk Range:128.50 - 349.08
    Volume:0
    Avg Vol (3m):631,106
    Market Cap:6.77B
    P/E (ttm):N/A
    EPS (ttm):-13.63
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ICPT 0.00%6.77B
    AZNDown 1.83%90.68B
    SLXP 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3,680.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-8.42
    Quarterly EPS Est (Mar-15) :-1.69
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-1.88

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid c... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback